secwatch / observer
8-K filed April 11, 2024, 7:59 PM ET ticker SLSN CIK 0000883107
litigation confidence high sentiment positive materiality 0.60

Nanophase settles BASF exclusivity litigation, amends supply agreement

SOLESENCE, INC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

SOLESENCE, INC. amended Amendment No. 5 to Zinc Oxide Supply Agreement with BASF Corporation valued at Amendment No. 5 to Zinc Oxide Supply Agreement, dated as of September 16, 1999, as amended, and Bind (effective 2024-04-10).

Action
amendment
Agreement
supply
Counterparty
BASF Corporation
Value
Amendment No. 5 to Zinc Oxide Supply Agreement, dated as of September 16, 1999, as amended, and Bind
Effective
2024-04-10
Exact text from the filing
on April 10, 2024, Nanophase Technologies Corporation (“Nanophase”) and BASF Corporation (“BASF”) entered into an Amendment No. 5 (the “Amendment”) to Zinc Oxide Supply Agreement, dated as of September 16, 1999, as amended (the “Agreement”), and a Binding Memorandum of Understanding regarding Nanophase using its commercially reasonable efforts to develop a modified zinc oxide product for BASF’s exclusive purchase under the Agreement (the “Modified Product MOU”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.85

SOLESENCE, INC. entered into Binding Memorandum of Understanding with BASF Corporation valued at Binding Memorandum of Understanding regarding Nanophase developing modified zinc oxide product for B (effective 2024-04-10).

Action
entry
Agreement
supply
Counterparty
BASF Corporation
Value
Binding Memorandum of Understanding regarding Nanophase developing modified zinc oxide product for B
Effective
2024-04-10
Exact text from the filing
on April 10, 2024, Nanophase Technologies Corporation (“Nanophase”) and BASF Corporation (“BASF”) entered into an Amendment No. 5 (the “Amendment”) to Zinc Oxide Supply Agreement, dated as of September 16, 1999, as amended (the “Agreement”), and a Binding Memorandum of Understanding regarding Nanophase using its commercially reasonable efforts to develop a modified zinc oxide product for BASF’s exclusive purchase under the Agreement (the “Modified Product MOU”).
View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

SOLESENCE, INC. filing history →

Source: SEC EDGAR
accession 0001171843-24-001961
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.